About Freenome
Freenome builds in the personal healthcare category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.
What they do: Freenome brings accurate and non-invasive disease screening to proactively treat cancer Personal Healthcare Biotech
Funding context: Andreessen Horowitz, Founders Fund, $254M Series E in 2024, $2.6B valuation
Recent milestones:
- Freenome appears in the 100Xfounder startup directory import feed.
Why it Matters
Freenome matters because freenome brings accurate and non-invasive disease screening to proactively treat cancer Personal Healthcare Biotech
Funding Snapshot
- Series E | Andreessen Horowitz, Founders Fund, $254M Series E in 2024, $2.6B valuation
Hiring Roles
This company is actively hiring.
Meet the Founders
Freenome Team
Founder & CEO
